Breast & Ovarian Cancer Panel
Colorectal Cancer Panel
Endocrine Tumor Panel
Pan-Cancer Hereditary Panel
Comprehensive Hereditary Cancer Panel (200+ genes)
For therapy selection and prognostication.
Solid Tumor NGS Panel
Comprehensive Tumor Panel
Actionable Mutation Panel
Acute Myeloid Leukemia (AML) Panel
Acute Lymphoblastic Leukemia (ALL) Panel
Myelodysplastic Syndrome (MDS) Panel
Myeloproliferative Neoplasm (MPN) Panel
Lymphoma Panel
HRD Testing (Homologous Recombination Deficiency)
Tumor Mutational Burden (TMB)
Microsatellite Instability (MSI)
PD-L1 related genomic markers
ctDNA based mutation analysis
Treatment response monitoring
Minimal Residual Disease (MRD) assessment
Resistance mutation detection
FISH for oncogene amplification / deletion
Karyotyping for hematological malignancies
CNV analysis by NGS / CMA
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.